IgA nephropathy: Difference between revisions
No edit summary |
No edit summary |
||
| Line 17: | Line 17: | ||
{{IgA nephropathy}} | {{IgA nephropathy}} | ||
{{CMG}};{{AE}}{{ | {{CMG}};{{AE}} {{Rim}};{{SH}};{{OO}};{{APM}} | ||
{{SK}} IgA nephritis; IgAN; Berger's disease; synpharyngitic glomerulonephritis, | {{SK}} IgA nephritis; IgAN; Berger's disease; synpharyngitic glomerulonephritis, | ||
Revision as of 13:53, 4 June 2018
For patient information click here Template:DiseaseDisorder infobox
|
IgA nephropathy Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
IgA nephropathy On the Web |
|
American Roentgen Ray Society Images of IgA nephropathy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Rim Halaby, M.D. [2];Dildar Hussain, MBBS [3];Olufunmilola Olubukola M.D.[4];Ali Poyan Mehr, M.D. [5]
Synonyms and keywords: IgA nephritis; IgAN; Berger's disease; synpharyngitic glomerulonephritis, IgA glomerulonephritis, IgAN - IgA nephropathy, Immunoglobulin A nephropathy
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating IgA nephropathy from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Study of Choice | History and Symptoms | Physical Examination | Laboratory Findings | Electrocardiogram | X-ray | CT | MRI | Echocardiography or Ultrasound |Other Imaging Findings | Other Diagnostic Studies
Treatment
Medical Therapy | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies